The Journal of Cell Biology · 2004 · 78 citations · 20 references
Life SciencesCell BiologyMolecular BiologyCell ProliferationCell SignalingSignal TransductionCalcium SignalingCancer Cell SignalingCell Signaling NetworksGrowth Factor SignalingCa2+ SignalingCancer Cell Proliferation InhibitionCancer Signaling PathwaysCell Growth Signaling PathwaysP21 RegulationTransforming Growth Factor Beta Signaling ModulationTransforming Growth Factor-beta Signaling
Growth regulation of epithelial cells is of major concern because most human cancers arise from them. We demonstrated previously a novel signal pathway involving S100C/A11 for high Ca2+-induced growth inhibition of normal human keratinocytes (Sakaguchi, M., M. Miyazaki, M. Takaishi, Y. Sakaguchi, E. Makino, N. Kataoka, H. Yamada, M. Namba, and N.H. Huh. 2003. J. Cell Biol. 163:825-835). This paper addresses a question whether transforming growth factor beta (TGFbeta) shares the pathway with high Ca2+. On exposure of the cells to TGFbeta1, S100C/A11 was phosphorylated, bound to nucleolin, and transferred to the nucleus, resulting in induction of p21WAF1/CIP1 and p15INK4B through activation of Sp1. Protein kinase C alpha (PKCalpha) was shown to phosphorylate 10Thr of S100C/A11, which is a critical event for the signal transduction. The TGFbeta1-induced growth inhibition was almost completely mitigated when PKCalpha activity was blocked or when S100C/A11 was functionally sequestered. These results indicate that, in addition to the well-characterized Smad-mediated pathway, the PKCalpha-S100C/A11-mediated pathway is involved in and essential for the growth inhibition of normal human keratinocytes cells by TGFbeta1.
20
Hiroshi Hanafusa, Jun Ninomiya‐Tsuji, Norihisa Masuyama et al. · Journal of Biological Chemistry · 1999 · 439 citations · Full text
Frequency of Smad gene mutations in human cancers.
Gregory J. Riggins, K. W. Kinzler, Bert Vogelstein et al. · PubMed · 1997 · 284 citations